XML 91 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION
6 Months Ended
Dec. 31, 2013
SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION [Abstract]  
SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

NOTE 11 - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

 

Balance sheets:

 

  a. Accounts receivable:

 

    6 month period ended     Year Ended June 30,  
    December 31, 2013     2013     2012  
    ($ in thousands)  
1)   Trade:                        
Open accounts   $ 2,260     $ 2,068     $ 2,039  
Allowance for doubtful accounts     (405 )     (329 )     (215 )
    $ 1,855     $ 1,739     $ 1,824  
2)   Other:                        
Due from government institutions   $ 221     $ 176     $ 124  
Advance payments to suppliers     152       202       118  
Miscellaneous     14       10       22  
    $ 387     $ 388     $ 264  

 

The changes in "Allowance for doubtful accounts" during the six month period ended December 31, 2013, as well as the years ended June 30, 2013 and 2012 are as follows:

 

    6 month period ended     Year ended June 30,  
    December 31, 2013     2013     2012  
    ($ in thousands)  
Balance at beginning of period   $ 329     $ 215     $ 155  
Additions during the period     58       245       78  
Deductions during the period             (142 )        
Exchange rate differences     18       11       (18 )
Balance at end of period   $ 405     $ 329     $ 215  

 

  b. Inventories:

 

    6 month period ended     Year ended June 30,  
    December 31, 2013     2013     2012  
    ($ in thousands)  
Finished goods   $ 1,097     $ 364     $ 479  
Work in process     341       1,111       1,115  
Raw materials and supplies     155       118       150  
    $ 1,593     $ 1,593     $ 1,744  

 

As of December 31, 2013, as well as June 30, 2013 and 2012 the Company recorded provisions for slow moving inventory in the amounts of $418,000, $379,000 and $443,000, respectively.

 

  c. Inventory on consignment

 

The changes in inventory on consignment during the six month period ended December 31, 2013, as well as the years ended June 30, 2013 and 2012 are as follows:

 

    6 month period ended,     Year ended June 30,  
    December 31, 2013     2013     2012  
    ($ in thousands)  
Balance at beginning of period   $ -     $ 63     $ 82  
Costs of revenues deferred during the period             20       63  
Costs of revenues recognized during the period             (83 )     (82 )
Balance at end of period   $ -     $ -     $ 63  

 

As of June 30, 2012, inventory on consignment included products of sales for which returns were reliably estimated in the amount of approximately $63,000. As of December 31, 2013 and June 30, 2013, there was no inventory on consignment.

 

  d. Accounts payable and accruals-other:

 

    6 month period ended     Year ended June 30,  
    December 31, 2013     2013     2012  
    ($ in thousands)  
Employees and employee institutions   $ 1,133     $ 626     $ 438  
Accrued vacation and recreation pay     325       313       272  
Accrued clinical trials expenses     622       513       607  
Provision for sales commissions     139       205       194  
Accrued expenses     886       1,343       1,197  
Due to government institutions     7       15       22  
Provision for returns                     139  
Taxes payable     29       13       56  
    $ 3,141     $ 3,028     $ 2,925  

 

Statements of Operation:

 

  f. Financial expenses, net:

 

    6 month period ended     Year ended June 30,  
    December 31, 2013     2013     2012  
    ($ in thousands)  
Bank commissions   $ 27     $ 38     $ 50  
Interest income     (2 )     (28 )     (40 )
Exchange rate differences     1       (63 )     112  
Induced conversion of convertible debt             9,330          
Issuance of warrants             568          
Interest expense (including debt issuance costs)     273       4,268       1,238  
Change in fair value of warrants, embedded derivatives and anti-dilution rights     200       64       (1,322 )
    $ 499     $ 14,177     $ 38